UBS Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23M | Buy |
320,172
+32,611
| +11% | +$1.86M | ﹤0.01% | 2427 |
|
|
2025
Q4 | $12.2M | Buy |
287,561
+196,739
| +217% | +$11M | ﹤0.01% | 3094 |
|
|
2025
Q3 | $5.17M | Sell |
90,822
-110,549
| -55% | -$3.66M | ﹤0.01% | 3995 |
|
|
2025
Q2 | $5.2M | Buy |
201,371
+179,550
| +823% | +$2.02M | ﹤0.01% | 3844 |
|
|
2025
Q1 | $223K | Buy |
21,821
+1,426
| +7% | +$18.6K | ﹤0.01% | 6478 |
|
|
2024
Q4 | $285K | Buy |
20,395
+12,894
| +172% | +$227K | ﹤0.01% | 6229 |
|
|
2024
Q3 | $146K | Buy |
7,501
+3,667
| +96% | +$69.9K | ﹤0.01% | 6087 |
|
|
2024
Q2 | $71.3K | Buy |
3,834
+3,621
| +1,700% | +$76.3K | ﹤0.01% | 6414 |
|
|
2024
Q1 | $2.98K | Sell |
213
-16,183
| -99% | -$169K | ﹤0.01% | 7794 |
|
|
2023
Q4 | $139K | Buy |
16,396
+13,136
| +403% | +$99.5K | ﹤0.01% | 5999 |
|
|
2023
Q3 | $29.1K | Buy |
3,260
+2,603
| +396% | +$25.1K | ﹤0.01% | 6600 |
|
|
2023
Q2 | $5.67K | Sell |
657
-77
| -10% | -$821 | ﹤0.01% | 7431 |
|
|
2023
Q1 | $7.74K | Sell |
734
-26
| -3% | -$787 | ﹤0.01% | 7780 |
|
|
2022
Q4 | $25.8K | Sell |
760
-229
| -23% | -$11.1K | ﹤0.01% | 7393 |
|
|
2022
Q3 | $48K | Buy |
989
+160
| +19% | +$9.52K | ﹤0.01% | 6386 |
|
|
2022
Q2 | $47K | Sell |
829
-413
| -33% | -$26.1K | ﹤0.01% | 5967 |
|
|
2022
Q1 | $101K | Sell |
1,242
-74
| -6% | -$11K | ﹤0.01% | 5907 |
|
|
2021
Q4 | $267K | Sell |
1,316
-771
| -37% | -$167K | ﹤0.01% | 5458 |
|
|
2021
Q3 | $562K | Sell |
2,087
-7,494
| -78% | -$1.8M | ﹤0.01% | 4656 |
|
|
2021
Q2 | $2.47M | Buy |
9,581
+3,726
| +64% | +$1.03M | ﹤0.01% | 3385 |
|
|
2021
Q1 | $1.76M | Sell |
5,855
-2,376
| -29% | -$740K | ﹤0.01% | 3691 |
|
|
2020
Q4 | $2.1M | Buy |
8,231
+34
| +0.4% | +$8.79K | ﹤0.01% | 3366 |
|
|
2020
Q3 | $2.04M | Buy |
8,197
+6,303
| +333% | +$1.98M | ﹤0.01% | 3017 |
|
|
2020
Q2 | $658K | Sell |
1,894
-3,723
| -66% | -$1.16M | ﹤0.01% | 3911 |
|
|
2020
Q1 | $1.5M | Sell |
5,617
-11,058
| -66% | -$3.42M | ﹤0.01% | 3025 |
|
|
2019
Q4 | $5.4M | Buy |
16,675
+4,585
| +38% | +$1.33M | ﹤0.01% | 2533 |
|
|
2019
Q3 | $3.3M | Buy |
12,090
+6,315
| +109% | +$2.32M | ﹤0.01% | 2786 |
|
|
2019
Q2 | $3.08M | Sell |
5,775
-567
| -9% | -$284K | ﹤0.01% | 2757 |
|
|
2019
Q1 | $3.2M | Buy |
6,342
+1,954
| +45% | +$1.16M | ﹤0.01% | 2575 |
|
|
2018
Q4 | $2.16M | Sell |
4,388
-3,000
| -41% | -$1.81M | ﹤0.01% | 2964 |
|
|
2018
Q3 | $6.76M | Buy |
7,388
+1,085
| +17% | +$926K | ﹤0.01% | 2092 |
|
|
2018
Q2 | $4.62M | Sell |
6,303
-5,880
| -48% | -$6.78M | ﹤0.01% | 2416 |
|
|
2018
Q1 | $19.4M | Buy |
12,183
+9,972
| +451% | +$12.8M | 0.01% | 1188 |
|
|
2017
Q4 | $1.98M | Sell |
2,211
-198
| -8% | -$117K | ﹤0.01% | 3210 |
|
|
2017
Q3 | $867K | Sell |
2,409
-859
| -26% | -$269K | ﹤0.01% | 3816 |
|
|
2017
Q2 | $958K | Buy |
3,268
+1,603
| +96% | +$463K | ﹤0.01% | 3655 |
|
|
2017
Q1 | $586K | Buy |
1,665
+142
| +9% | +$31.9K | ﹤0.01% | 3930 |
|
|
2016
Q4 | $280K | Buy |
1,523
+1,448
| +1,931% | +$294K | ﹤0.01% | 4535 |
|
|
2016
Q3 | $19K | Sell |
75
-156
| -68% | -$40.2K | ﹤0.01% | 6335 |
|
|
2016
Q2 | $50K | Sell |
231
-62
| -21% | -$13.9K | ﹤0.01% | 5521 |
|
|
2016
Q1 | $60K | Buy |
293
+8
| +3% | +$1.54K | ﹤0.01% | 5356 |
|
|
2015
Q4 | $72K | Buy |
285
+8
| +3% | +$1.65K | ﹤0.01% | 5501 |
|
|
2015
Q3 | $45K | Sell |
277
-1,179
| -81% | -$209K | ﹤0.01% | 5933 |
|
|
2015
Q2 | $273K | Sell |
1,456
-177
| -11% | -$30.5K | ﹤0.01% | 4604 |
|
|
2015
Q1 | $270K | Buy |
1,633
+1,401
| +604% | +$288K | ﹤0.01% | 4641 |
|
|
2014
Q4 | $54K | Buy |
+232
| New | +$49.6K | ﹤0.01% | 6396 |
|
Other funds holding NKTR
BI
TSC
VCM
PM
AC
